Symptomatic and disease-modifying therapy for the progressive ataxias.
about
Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in SpainEffects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.An approach to the patient with late-onset cerebellar ataxia.
P2860
Symptomatic and disease-modifying therapy for the progressive ataxias.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Symptomatic and disease-modifying therapy for the progressive ataxias.
@ast
Symptomatic and disease-modifying therapy for the progressive ataxias.
@en
type
label
Symptomatic and disease-modifying therapy for the progressive ataxias.
@ast
Symptomatic and disease-modifying therapy for the progressive ataxias.
@en
prefLabel
Symptomatic and disease-modifying therapy for the progressive ataxias.
@ast
Symptomatic and disease-modifying therapy for the progressive ataxias.
@en
P1433
P1476
Symptomatic and disease-modifying therapy for the progressive ataxias.
@en
P2093
Susan L Perlman
P304
P356
10.1097/01.NRL.0000141651.35193.67
P407
P577
2004-09-01T00:00:00Z